CIK 0001610820 · Non-accelerated filer<br>Smaller reporting company
BriaCell Therapeutics Corp.
Sign in to watch- Ticker
- BCTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jul 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 921-1810
- Business address
- 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER, British Columbia, Canada, V7T 2X1
- Former names
- Ansell Capital Corp.
Securities
- BCTX Common Shares Nasdaq
- BCTXL Warrants Nasdaq
- BCTXZ Warrant Nasdaq
- DRS Other Draft Registration Statement
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- 40-F/A Report 40-F/A
- 40-F Report 40-F
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- CERT Other Certification
- 8-A12B Other Registration of Securities
- DEL AM Other DEL AM
- DRS Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
Page 2 of 3 · 41 filings